Study protocol of the LARK (TROG 17.03) clinical trial: a phase II trial investigating the dosimetric impact of Liver Ablative Radiotherapy using Kilovoltage intrafraction monitoring

BACKGROUND: Stereotactic Ablative Body Radiotherapy (SABR) is a non-invasive treatment which allows delivery of an ablative radiation dose with high accuracy and precision. SABR is an established treatment for both primary and secondary liver malignancies, and technological advances have improved it...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yoo Young Dominique, Nguyen, Doan Trang, Moodie, Trevor, O’Brien, Ricky, McMaster, Anne, Hickey, Andrew, Pritchard, Nicole, Poulsen, Per, Tabaksblat, Elizaveta Mitkina, Weber, Britta, Worm, Esben, Pryor, David, Chu, Julie, Hardcastle, Nicholas, Booth, Jeremy, Gebski, Val, Wang, Tim, Keall, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091536/
https://www.ncbi.nlm.nih.gov/pubmed/33941111
http://dx.doi.org/10.1186/s12885-021-08184-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091536/
https://www.ncbi.nlm.nih.gov/pubmed/33941111
http://dx.doi.org/10.1186/s12885-021-08184-x

Ejemplares similares